Innovative Trends in eHealth for Pharma Development in Europe - Drug Discovery TOE

USD 950.00

* Required Fields

USD 950.00


Be the first to review this product

This edition of the Drug Discovery TOE depicts developments associated with innovations in eHealth for pharmaceutical development in Europe.The corresponding patent scenario and industry interactions are depicted, illustrating the advent of eHealth platforms in pharmaceutical development, with a special focus on European countries.The Drug Discovery TechVision Opportunity Engine (TOE) reports and analyzes about the latest developments in drug discovery and therapeutics, thereby providing an opportunity to acquire strategic insights into crucial developments in this industry domain. Technologies profiled include those used for biomarker and target discovery such as high throughput screening, signal transduction

Table of Contents

Innovative Trends in eHealth for Pharma Development in Europe - Drug Discovery TOERegional Trend OverviewInnovative Trends in eHealth for Pharma Development in EuropeTechnology ProfilesSpanish Science, Technology and Innovation Strategy 2013-2020Spanish Innovation Capabilities in the Murcia RegionTICBioMedeHealth Solutions in The NetherlandsDigital Health Solutions in UK Clinical Decision Support Solutions in PortugalNeurohealth Evaluation in SpainOnline Therapy in the NetherlandsAppendixPatent AnalysisPatent AnalysisPatent AnalysisIndustry InteractionsIndustry Interactions

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.